Chinese researchers develop probiotic aimed at simplifying diabetes management
Scientists in China have created a probiotic that could turn diabetes care into a routine like drinking yoghurt or taking a capsule, with plans to enter the U.S. market within two years.
A team of Chinese researchers engineered a probiotic designed to help control blood-sugar levels, potentially allowing patients to manage diabetes through everyday foods or a simple supplement. The developers say the product could be ready for sale in the United States in about two years. This approach seeks to make treatment more convenient compared with traditional medication regimens. No clinical trial results have been disclosed yet.
Why it matters
It could make diabetes treatment more accessible and less burdensome for millions of patients.
In this story
